Parkinson’s Disease Drug Therapies in the... - Cure Parkinson's

Cure Parkinson's

25,343 members26,643 posts

Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020

Farooqji profile image
12 Replies

145 trials are registered and ongoing clinical trials for therapeutics targeting PD, of which 51 were Phase 1 (35% of the total number of trials), 66 were Phase 2 (46% ), and 28 were Phase 3 (19% ). There were 57 trials (39% ) focused on long-term disease modifying therapies, with the remaining 88 trials (61% ) focused on therapies for symptomatic relief. A total of 50 (34% ) trials were testing

content.iospress.com/articl...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
12 Replies
MissRita profile image
MissRita

Does anyone know how you get on board for a trial? I would love to be a guinea pig for the stuff but I just don’t know where to start. TIA!

Farooqji profile image
Farooqji in reply to MissRita

Go to clinicaltrials.gov, Search for the required trial and contact them as per the contract information provided

MissRita profile image
MissRita in reply to Farooqji

Thx!

WinnieThePoo profile image
WinnieThePoo in reply to MissRita

Michael J Fox foundation also have a trial finder site

michaeljfox.org/trial-finder

MissRita profile image
MissRita in reply to WinnieThePoo

Thx!

redhawk1 profile image
redhawk1

Stay tuned for study results of Phase 1 Denali DNL 151. If I were to get involved with another trial I would certainly consider the Denali Therapeutics Phase 2 DNL151 trial scheduled to begin sometime this year. Also, get a genetic test to determine specific genes that may be responsible for your disease inception.

Farooqji profile image
Farooqji in reply to redhawk1

Were you involved in Phase1? How was it

redhawk1 profile image
redhawk1 in reply to Farooqji

No. I am in Roche Prothena 2b study. But, trial center I attend is also sponsoring the Denali DNL151 phase 1 study. I always try to obtain snippets of information about other studies when I am there. The 5 cohorts taking part in the phase 1 Denali study all had “positive” reactions to the DNL151 medication. Had not heard such an endorsement about any other PD drug in my three years there as trial givers are hesitant to disclose any thoughts . . ., as they should be. Just saying . . .

Farooqji profile image
Farooqji in reply to redhawk1

How is PRX002 going. Any improvements reported by the participants?

redhawk1 profile image
redhawk1 in reply to Farooqji

Diagnosed March/2017 and in year 3 of study. Currently not taking any PD meds. Symptoms have progressed none the less . . . all be it slowly. Roche phase 2b apparently to continue up to 5 years.

MissRita profile image
MissRita in reply to redhawk1

I have been looking to get genetically tested but I’m not sure where or how to do it. Suggestions?

John_morris71 profile image
John_morris71

Anavex will soon be starting phase2/3 trial for PD using their drug A 2-73 which is a Sigma 1 Receptor. They had good results for PDD (Parkinson's Disease Dementia) and more details will soon be published in a peer review.

You may also like...

Light Therapy Clinical Trial

place for our Celeste Light for PD trial—a phase 3 clinical trial in which we will show the efficacy

Light Therapy for Parkinson’s Disease

light therapy information together in one place:...

Electroconvulsive Therapy Intervention for Parkinson’s Disease

Electroconvulsive Therapy Intervention for Parkinson’s Disease...

Parkinson’s disease stem cell therapy research update

for Parkinson’s. https://ipscell.com/2022/10/parkinsons-disease-stem-cell-therapy-research-update/

How vibration therapy can alleviate tremors caused by Parkinson’s disease

https://www.brownmed.com/blog/vibration-therapy/how-vibration-therapy-can-alleviate-tremors-caused-